Validation of protein arginine methyltransferase 5 (PRMT5) as a candidate therapeutic target in the spontaneous canine model of non-Hodgkin lymphoma is a research paper published in PLoS ONE (2021). On theSindex it has a DataRank of 0.345. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Morris Animal Foundation
Grant: D15CA-026
National Cancer Institute
Grant: P30 CA016058
Center for Clinical and Translational Science, Ohio State University
Grant: UL1TR002733
OSU College of Veterinary Medicine Canine Grant
Grant: 2016-06
National Institutes of Health
Grant: 5UL1TR002733-02
The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health
National Institutes of Health
Grant: 3P30CA016058-15S1
CORE--HORMONE RECEPTOR LABORATORY
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals